Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_assertion description "[The evidence for prostate cancer risk reduction with the mono 5?-reductase inhibitor (5ARI) finasteride in a low-risk population and, more recently, with the dual 5ARI dutasteride in a population at increased risk of developing the disease, has potential to expand management options for men at risk of developing prostate cancer beyond more frequent and/or earlier surveillance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_assertion evidence source_evidence_literature NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_assertion SIO_000772 21166744 NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_assertion wasDerivedFrom befree-2016 NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_assertion wasGeneratedBy ECO_0000203 NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.
- befree-2016 importedOn "2016-02-19" NP859866.RAx7Z347t0GOqyT4k1eeja3wRD6K78ot_XsxGjNzKjxs4130_provenance.